The T2DM mouse model showed a reduced activation of pancreatic β cell Dnmt1 and reduced Nr4a1 hypermethylation when treated with the DNMT1 inhibitor aurintricarboxylic acid (ATA). This evidence concerns the gene DNMT1 and type 2 diabetes mellitus.